FriedL.F., BernardiniJ., JohnstonJ.R., PirainoB.Peritonitis influences mortality in peritoneal dialysis patients.J Am Soc Nephrol1996; 7(10): 2176–82.
2.
WoodrowG., TurneyJ.H., BrownjohnA.M.Technique failure in peritoneal dialysis and its impact on patient survival.Perit Dial Int1997; 17(4): 360–4.
3.
ChoiP., NematiE., BanerjeeA., PrestonE., LevyJ., BrownE.Peritoneal dialysis catheter removal for acute peritonitis: A retrospective analysis of factors associated with catheter removal and prolonged postoperative hospitalization.Am J Kidney Dis2004; 43(1): 103–11.
4.
SzetoC.C., ChowK.M., WongT.Y., LeungC.B., LiP.K.Conservative management of polymicrobial peritonitis complicating peritoneal dialysis–a series of 140 consecutive cases.Am J Med2002; 113(9): 728–33.
5.
BaystonR., AndrewsM., RiggK., SheltonA.Recurrent infection and catheter loss in patients on continuous ambulatory peritoneal dialysis.Perit Dial Int1999; 19(6): 550–5.
6.
BunkeC.M., BrierM.E., GolperT.A.Outcomes of single organism peritonitis in peritoneal dialysis: Gram-negatives versus gram-positives in the Network 9 Peritonitis Study.Kidney Int1997; 52(2): 524–9.
7.
PirainoB., BernardiniJ., SorkinM.The influence of peritoneal catheter exit-site infections on peritonitis, tunnel infections, and catheter loss in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1986; 8(6): 436–40.
8.
PirainoB., BernardiniJ., SorkinM.Catheter infections as a factor in the transfer of continuous ambulatory peritoneal dialysis patients to hemodialysis.Am J Kidney Dis1989; 13(5): 365–9.
9.
KeaneW.F., EverettE.D., GolperT.A., GokalR., HalstensonC., KawaguchiY.Peritoneal dialysis-related peritonitis treatment recommendations. 1993 update. The Ad Hoc Advisory Committee on Peritonitis Management. International Society for Peritoneal Dialysis.Perit Dial Int1993; 13(1): 14–28.
BorgD., ShettyA., WilliamsD., FaberM.D.Fivefold reduction in peritonitis using a multifaceted continuous quality initiative program.Adv Perit Dial2003; 19: 202–5.
13.
Diaz-BuxoJ.A., WickG.S., PesichA.A.Using CQI techniques for managing infections in PD patients.Nephrol News Issues1998; 12(11): 22–4.
14.
SchaeferF., KandertM., FenebergR.Methodological issues in assessing the incidence of peritoneal dialysis-associated peritonitis in children.Perit Dial Int2002; 22(2): 234–8.
15.
LiP.K., LawM.C., ChowK.M., ChanW.K., SzetoC.C., ChengY.L.Comparison of clinical outcome and ease of handling in two double-bag systems in continuous ambulatory peritoneal dialysis: A prospective, randomized, controlled, multicenter study.Am J Kidney Dis2002; 40(2): 373–80.
16.
KimD.K., YooT.H., RyuD.R., XuZ.G., KimH.J., ChoiK.H.Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: A single center's experience over one decade.Perit Dial Int2004; 24: 424–32.
Rodriguez-CarmonaA., Perez FontanM., Garcia FalconT., Fernandez RiveraC., ValdesF.A comparative analysis on the incidence of peritonitis and exit-site infection in CAPD and automated peritoneal dialysis.Perit Dial Int1999; 19(3): 253–8.
19.
de FijterC.W., OeP.L., NautaJ.J., van der MeulenJ., ter WeeP.M., SnoekF.J.A prospective, randomized study comparing the peritonitis incidence of CAPD and Y-connector (CAPD-Y) with continuous cyclic peritoneal dialysis (CCPD).Adv Perit Dial1991; 7: 186–9.
20.
de FijterC.W., VerbrughH.A., OeL.P., PetersE.D., van der MeulenJ., DonkerA.J.Peritoneal defense in continuous ambulatory versus continuous cyclic peritoneal dialysis.Kidney Int1992; 42(4): 947–50.
21.
de FijterC.W., OeL.P., NautaJ.J., van der MeulenJ., VerbrughH.A., VerhoefJ.Clinical efficacy and morbidity associated with continuous cyclic compared with continuous ambulatory peritoneal dialysis [see Comment].Ann Intern Med1994; 120(4): 264–71.
ChowJ., MunroC., WongM., GonzalezN., KuM., NevilleS.HomeChoice automated peritoneal dialysis machines: The impact of reuse of tubing and cassettes.Perit Dial Int2000; 20(3): 336–8.
24.
PonferradaL.P., ProwantB.F., RackersJ.A., PickettB., SatalowichR., KhannaR.A cluster of gram-negative peritonitis episodes associated with reuse of HomeChoice cycler cassettes and drain lines.Perit Dial Int1996; 16(6): 636–8.
25.
StrippoliG.F.M., TongA., JohnsonD., SchenaF.P., CraigJ.C.Catheter-related interventions to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials.J Am Soc Nephrol2004; 15(10): 2735–46.
26.
AkyolA.M., PorteousC., BrownM.W.A comparison of two types of catheters for continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Int1990; 10(1): 63–6.
27.
DanielssonA., BlohmeL., TranaeusA., HylanderB.A prospective randomized study of the effect of a subcutaneously “buried” peritoneal dialysis catheter technique versus standard technique on the incidence of peritonitis and exit-site infection.Perit Dial Int2002; 22(2): 211–19.
28.
EklundB.H., HonkanenE.O., KalaA.R., KyllonenL.E.Catheter configuration and outcome in patients on continuous ambulatory peritoneal dialysis: A prospective comparison of two catheters.Perit Dial Int1994; 14(1): 70–4.
29.
EklundB.H., HonkanenE.O., KalaA.R., KyllonenL.E.Peritoneal dialysis access: Prospective randomized comparison of the swan neck and Tenckhoff catheters [see Comment].Perit Dial Int1995; 15(8): 353–6.
GadallahM.F., PervezA., el-ShahawyM.A., SorrellsD., ZibariG., McDonaldJ.Peritoneoscopic versus surgical placement of peritoneal dialysis catheters: A prospective randomized study on outcome.Am J Kidney Dis1999; 33(1): 118–22.
32.
GolperT.A., BrierM.E., BunkeM., SchreiberM.J., BartlettD.K., HamiltonR.W.Risk factors for peritonitis in long-term peritoneal dialysis: The Network 9 Peritonitis and Catheter Survival Studies. Academic Subcommittee of the Steering Committee of the Network 9 Peritonitis and Catheter Survival Studies.Am J Kidney Dis1996; 28(3): 428–36.
33.
LindbladA.S., HamiltonR.W., NolphK.D., NovakJ.W.A retrospective analysis of catheter configuration and cuff type: A National CAPD Registry report.Perit Dial Int1988; 8: 129–33.
34.
LyeW.C., KourN.W., van der StraatenJ.C., LeongS.O., LeeE.J.A prospective randomized comparison of the swan neck, coiled, and straight Tenckhoff catheters in patients on CAPD.Perit Dial Int1996; 16(Suppl 1): S333–5.
35.
ParkM.S., YimA.S., ChungS.H., LeeE.Y., ChaM.K., KimJ.H.Effect of prolonged subcutaneous implantation of peritoneal catheter on peritonitis rate during CAPD: A prospective randomized study.Blood Purif1998; 16(3): 171–8.
36.
Bennett-JonesD.N., MartinJ., BarrattA.J., DuffyT.J., NaishP.F., AberG.M.Prophylactic gentamicin in the prevention of early exit-site infections and peritonitis in CAPD.Adv Perit Dial1988; 4: 147–50.
37.
GadallahM.F., RamdeenG., MignoneJ., PatelD., MitchellL., TatroS.Role of preoperative antibiotic prophylaxis in preventing postoperative peritonitis in newly placed peritoneal dialysis catheters.Am J Kidney Dis2000; 36(5): 1014–19.
38.
LyeW.C., LeeE.J., TanC.C.Prophylactic antibiotics in the insertion of Tenckhoff catheters.Scand J Urol Nephrol1992; 26(2): 177–80.
39.
WikdahlA.M., EngmanU., StegmayrB.G., SorenssenJ.G.One-dose cefuroxime i.v. and i.p. reduces microbial growth in PD patients after catheter insertion.Nephrol Dial Transplant1997; 12(1): 157–60.
40.
TwardowskiZ.J., DobbieJ.W., MooreH.L., NicholsW.K., DeSpainJ.D., AndersonP.C.Morphology of peritoneal dialysis catheter tunnel: Macroscopy and light microscopy.Perit Dial Int1991; 11(3): 237–51.
41.
LoW.K., LuiS.L., LiF.K., ChoyB.Y., LamM.F., TseK.C.A prospective randomized study on three different peritoneal dialysis catheters.Perit Dial Int2003; 23(Suppl 2): S127–31.
42.
TacconelliE., CarmeliY., AizerA., FerreiraG., ForemanM.G., D'AgataE.M.Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: A meta-analysis.Clin Infect Dis2003; 37(12): 1629–38.
43.
StrippoliG.F.M., TongA., JohnsonD., SchenaF.P., CraigJ.C.Antimicrobial agents to prevent peritonitis in peritoneal dialysis: A systematic review of randomized controlled trials.Am J Kidney Dis2004; 44: 592–603.
44.
AmatoD., de Jesus VenturaM., MirandaG., LeanosB., AlcantaraG., HurtadoM.E.Staphylococcal peritonitis in continuous ambulatory peritoneal dialysis: Colonization with identical strains at exit site, nose, and hands.Am J Kidney Dis2001; 37(1): 43–8.
45.
LyeW.C., LeongS.O., van der StraatenJ., LeeE.J.Staphylococcus aureus CAPD-related infections are associated with nasal carriage.Adv Perit Dial1994; 10: 163–5.
46.
LyeW.C., LeongS.O., LeeE.J.Methicillin-resistant Staphylococcus aureus nasal carriage and infections in CAPD.Kidney Int1993; 43(6): 1357–62.
47.
BernardiniJ., PirainoB., HolleyJ., JohnstonJ.R., LutesR.A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.Am J Kidney Dis1996; 27: 695–700.
48.
BernardiniJ., BenderF., FlorioT., SloandJ., PalmMontalbanoL., FriedL.Randomized double blinded trial of antibiotic exit site cream for the prevention of exit site infection in peritoneal dialysis patients.J Am Soc Nephrol2005; 16: 539–45.
49.
HerwaldtL.A., BoykenL.D., CoffmanS., HochstetlerL., FlaniganM.J.Sources of Staphylococcus aureus for patients on continuous ambulatory peritoneal dialysis.Perit Dial Int2003; 23(3): 237–41.
50.
LobbedezT., GardamM., DedierH., BurdzyD., ChuM., IzattS.Routine use of mupirocin at the peritoneal catheter exit site and mupirocin resistance: Still low after 7 years.Nephrol Dial Transplant2004; 19: 3140–3.
51.
Perez-FontanM., RosalesM., Rodriguez-CarmonaA., FalconT.G., ValdesF.Mupirocin resistance after long-term use for Staphylococcus aureus colonization in patients undergoing chronic peritoneal dialysis.Am J Kidney Dis2002; 39(2): 337–41.
52.
Mupirocin Study Group.Nasal mupirocin prevents Staphylococcus aureus exit-site infection during peritoneal dialysis. Mupirocin Study Group.J Am Soc Nephrol1996; 7(11): 2403–8.
53.
ZimmermanS.W., AhrensE., JohnsonC.A., CraigW., LeggettJ., O'BrienM.Randomized controlled trial of prophylactic rifampin for peritoneal dialysis-related infections.Am J Kidney Dis1991; 18(2): 225–31.
VychytilA., LorenzM., SchneiderB., HorlW.H., Haag-WeberM.New strategies to prevent Staphylococcus aureus infections in peritoneal dialysis patients.J Am Soc Nephrol1998; 9(4): 669–76.
56.
WongS.S., ChuK., CheukA., TsangW.K., FungS.K.S., ChanH.W.H.Prophylaxis against gram-positive organisms causing exit-site infection and peritonitis in continuous ambulatory peritoneal dialysis patients by applying mupirocin ointment at the catheter exit site.Perit Dial Int2003; 23(Suppl 2): S153–8.
57.
ZeybelM., OzderA., SanlidagC., YildizS., CavdarC., ErsoyR.The effects of weekly mupirocin application on infections in continuous ambulatory peritoneal dialysis patients.Adv Perit Dial2003; 19: 198–201.
58.
PirainoB., BernardiniJ., FlorioT., FriedL.Staphylococcus aureus prophylaxis and trends in gram-negative infections in peritoneal dialysis patients.Perit Dial Int2003; 23(5): 456–9.
59.
Perez-FontanM., RosalesM., Rodriguez-CarmonaA., MoncalianJ., Fernandez-RiveraC., CaoM.Treatment of Staphylococcus aureus nasal carriers in CAPD with mupirocin.Adv Perit Dial1992; 8: 242–5.
60.
LuzarM.A., BrownC.B., BalfD., HillL., IssadB., MonnierB.Exit-site care and exit-site infection in continuous ambulatory peritoneal dialysis (CAPD): Results of a randomized multicenter trial.Perit Dial Int1990; 10(1): 25–9.
61.
AnnigeriR., ConlyJ., VasS., DedierH., PrakashanK.P., BargmanJ.M.Emergence of mupirocin-resistant Staphylococcus aureus in chronic peritoneal dialysis patients using mupirocin prophylaxis to prevent exit-site infection.Perit Dial Int2001; 21(6): 554–9.
62.
AhnC., OhK.H., KimK., LeeK.Y., LeeJ.G., OhM.D.Effect of peritoneal dialysis on plasma and peritoneal fluid concentrations of isoniazid, pyrazinamide, and rifampin.Perit Dial Int2003; 23(4): 362–7.
63.
MontenegroJ., SarachoR., AguirreR., MartinezI., IribarI., OcharanJ.Exit-site care with ciprofloxacin otologic solution prevents polyurethane catheter infection in peritoneal dialysis patients.Perit Dial Int2000; 20(2): 209–14.
64.
Canadian CAPD Clinical Trials Group.Peritonitis in continuous ambulatory peritoneal dialysis (CAPD): A multicentre randomized clinical trial comparing the Y connector disinfectant system to standard systems. Canadian CAPD Clinical Trials Group [see Comment].Perit Dial Int1989; 9(3): 159–63.
65.
HarrisD.C., YuillE.J., BythK., ChapmanJ.R., HuntC.Twin- versus single-bag disconnect systems: Infection rates and cost of continuous ambulatory peritoneal dialysis.J Am Soc Nephrol1996; 7(11): 2392–8.
66.
KiernanL., KligerA., Gorban-BrennanN., JuergensenP., TesinD., VoneshE.Comparison of continuous ambulatory peritoneal dialysis-related infections with different “Y-tubing” exchange systems.J Am Soc Nephrol1995; 5(10): 1835–8.
67.
LiP.K., SzetoC.C., LawM.C., ChauK.F., FungK.S., LeungC.B.Comparison of double-bag and Y-set disconnect systems in continuous ambulatory peritoneal dialysis: A randomized prospective multicenter study [see Comment].Am J Kidney Dis1999; 33(3): 535–40.
68.
MonteonF., Correa-RotterR., PaniaguaR., AmatoD., HurtadoM.E., MedinaJ.L.Prevention of peritonitis with disconnect systems in CAPD: A randomized controlled trial. The Mexican Nephrology Collaborative Study Group.Kidney Int1998; 54(6): 2123–8.
69.
ProwantB.F.Nursing interventions related to peritonitis.Adv Ren Replace Ther1996; 3(3): 237–9.
70.
MillerT.E., FindonG.Touch contamination of connection devices in peritoneal dialysis–a quantitative microbiologic analysis.Perit Dial Int1997; 17(6): 560–7.
SingharetnamW., HolleyJ.L.Acute treatment of constipation may lead to transmural migration of bacteria resulting in gram-negative, polymicrobial, or fungal peritonitis.Perit Dial Int1996; 16(4): 423–5.
74.
WoodC.J., FlemingV., TurnidgeJ., ThomsonN., AtkinsR.C.Campylobacter peritonitis in continuous ambulatory peritoneal dialysis: Report of eight cases and a review of the literature.Am J Kidney Dis1992; 19(3): 257–63.
75.
PrasadK.N., PrasadN., GuptaA., SharmaR.K., VermaA.K., AyyagariA.Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: A single centre Indian experience.J Infect2004; 48(1): 96–101.
76.
WangA.Y., YuA.W., LiP.K., LamP.K., LeungC.B., LaiK.N.Factors predicting outcome of fungal peritonitis in peritoneal dialysis: Analysis of a 9-year experience of fungal peritonitis in a single center.Am J Kidney Dis2000; 36(6): 1183–92.
77.
GoldieS.J., Kiernan-TridleL., TorresC., Gorban-BrennanN., DunneD., KligerA.S.Fungal peritonitis in a large chronic peritoneal dialysis population: A report of 55 episodes.Am J Kidney Dis1996; 28(1): 86–91.
78.
ZarubaK., PetersJ., JungbluthH.Successful prophylaxis for fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: Six years’ experience [Published erratum appears in Am J Kidney Dis 1991; 17(6): 726].Am J Kidney Dis1991; 17(1): 43–6.
79.
RobitailleP., MerouaniA., ClermontM.J., HebertE.Successful antifungal prophylaxis in chronic peritoneal dialysis: A pediatric experience.Perit Dial Int1995; 15(1): 77–9.
80.
ThodisE., VasS.I., BargmanJ.M., SinghalM., ChuM., OreopoulosD.G.Nystatin prophylaxis: Its inability to prevent fungal peritonitis in patients on continuous ambulatory peritoneal dialysis [see Comment].Perit Dial Int1998; 18(6): 583–9.
81.
WadhwaN.K., SuhH., CabraldaT.Antifungal prophylaxis for secondary fungal peritonitis in peritoneal dialysis patients.Adv Perit Dial1996; 12: 189–91.
82.
WilliamsP.F., MoncrieffN., MarriottJ.No benefit in using nystatin prophylaxis against fungal peritonitis in peritoneal dialysis patients.Perit Dial Int2000; 20(3): 352–3.
83.
LoW.K., ChanC.Y., ChengS.W., PoonJ.F., ChanD.T., ChengI.K.A prospective randomized control study of oral nystatin prophylaxis for Candida peritonitis complicating continuous ambulatory peritoneal dialysis.Am J Kidney Dis1996; 28(4): 549–52.
84.
AbrahamG., SavinE., AyiomamitisA., IzattS., VasS.I., MatthewsR.E.Natural history of exit-site infection (ESI) in patients on continuous ambulatory peritoneal dialysis (CAPD).Perit Dial Bull1988; 8: 211–16.
85.
GonthierD., BernardiniJ., HolleyJ.L., PirainoB.Erythema: Does it indicate infection in a peritoneal catheter exit site?Adv Perit Dial1992; 8: 230–3.
SchaeferF., KlausG., Muller-WiefelD.E., MehlsO.Intermittent versus continuous intraperitoneal glycopeptide/ceftazidime treatment in children with peritoneal dialysis-associated peritonitis. The Mid-European Pediatric Peritoneal Dialysis Study Group (MEPPS).J Am Soc Nephrol1999; 10(1): 136–45.
88.
PlumJ., SudkampS., GrabenseeB.Results of ultrasound-assisted diagnosis of tunnel infections in continuous ambulatory peritoneal dialysis.Am J Kidney Dis1994; 23(1): 99–104.
89.
GuptaB., BernardiniJ., PirainoB.Peritonitis associated with exit site and tunnel infections.Am J Kidney Dis1996; 28(3): 415–19.
BunkeM., BrierM.E., GolperT.A.Pseudomonas peritonitis in peritoneal dialysis patients: The Network #9 Peritonitis Study.Am J Kidney Dis1995; 25(5): 769–74.
93.
KazmiH.R., RaffoneF.D., KligerA.S., FinkelsteinF.O.Pseudomonas exit site infections in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol1992; 2(10): 1498–501.
94.
JuergensenP.H., FinkelsteinF.O., BrennanR., SantacroceS., AhernM.J.Pseudomonas peritonitis associated with continuous ambulatory peritoneal dialysis: A six-year study.Am J Kidney Dis1988; 11(5): 413–17.
95.
SchifflH., MuckeC., LangS.M.Exit-site infections by nondiphtheria corynebacteria in CAPD.Perit Dial Int2004; 24(5): 454–9.
96.
LuiS.L., LiF.K., LoC.Y., LoW.K.Simultaneous removal and reinsertion of Tenckhoff catheters for the treatment of refractory exit-site infection.Adv Perit Dial2000; 16: 195–7.
97.
PosthumaN., BorgsteinP.J., EijsboutsQ., ter WeeP.M.Simultaneous peritoneal dialysis catheter insertion and removal in catheter-related infections without interruption of peritoneal dialysis.Nephrol Dial Transplant1998; 13(3): 700–3.
98.
CancariniG.C., ManiliL., BrunoriG., CameriniC., ZubaniR., ColombritaD.Simultaneous catheter replacement-removal during infectious complications in peritoneal dialysis.Adv Perit Dial1994; 10: 210–13.
99.
SwartzR., MessanaJ., ReynoldsJ., RanjitU.Simultaneous catheter replacement and removal in refractory peritoneal dialysis infections.Kidney Int1991; 40(6): 1160–5.
100.
VychytilA., LorenzM., SchneiderB., HorlW.H., Haag-WeberM.New criteria for management of catheter infections in peritoneal dialysis patients using ultrasonography.J Am Soc Nephrol1998; 9(2): 290–6.
101.
GouldI.M., CasewellM.W.The laboratory diagnosis of peritonitis during continuous ambulatory peritoneal dialysis.J Hosp Infect1986; 7(2): 155–60.
102.
BetjesM.G., TukC.W., VisserC.E., ZemelD., KredietR.T., AriszL.Analysis of the peritoneal cellular immune system during CAPD shortly before a clinical peritonitis.Nephrol Dial Transplant1994; 9(6): 684–92.
103.
FlaniganM.J., FreemanR.M., LimV.S.Cellular response to peritonitis among peritoneal dialysis patients.Am J Kidney Dis1985; 6(6): 420–4.
104.
FusshollerA., zur NiedenS., GrabenseeB., PlumJ.Peritoneal fluid and solute transport: Influence of treatment time, peritoneal dialysis modality, and peritonitis incidence.J Am Soc Nephrol2002; 13(4): 1055–60.
RocklinM.A., TeitelbaumI.Noninfectious causes of cloudy peritoneal dialysate.Semin Dial2001; 14(1): 37–40.
107.
ToureF., LavaudS., MohajerM., LavaudF., CanivetE., NguyenP.Icodextrin-induced peritonitis: Study of five cases and comparison with bacterial peritonitis [see Comment].Kidney Int2004; 65(2): 654–60.
108.
WolfsonM., PirainoB., HamburgerR.J., MortonA.R., Icodextrin StudyG.A randomized controlled trial to evaluate the efficacy and safety of icodextrin in peritoneal dialysis.Am J Kidney Dis2002; 40(5): 1055–65.
109.
PosthumaN., ter WeeP., DonkerA.J., DekkerH.A., OeP.L., VerbrughH.A.Peritoneal defense using icodextrin or glucose for daytime dwell in CCPD patients.Perit Dial Int1999; 19(4): 334–42.
110.
GokalR., MistryC.D., PeersE.M.Peritonitis occurrence in a multicenter study of icodextrin and glucose in CAPD. MIDAS Study Group. Multicenter investigation of icodextrin in ambulatory dialysis.Perit Dial Int1995; 15(6): 226–30.
111.
AlfaM.J., DegagneP., OlsonN., HardingG.K.Improved detection of bacterial growth in continuous ambulatory peritoneal dialysis effluent by use of BacT/Alert FAN bottles.J Clin Microbiol1997; 35(4): 862–6.
112.
SewellD.L., GolperT.A., HulmanP.B., ThomasC.M., WestL.M., KubeyW.Y.Comparison of large volume culture to other methods for isolation of microorganisms from dialysate.Perit Dial Int1990; 10(1): 49–52.
113.
LyeW.C., WongP.L., LeongS.O., LeeE.J.Isolation of organisms in CAPD peritonitis: A comparison of two techniques.Adv Perit Dial1994; 10: 166–8.
114.
Van BiesenW., VanholderR., VogelaersD., PelemanR., VerschraegenG., VijtD.The need for a center-tailored treatment protocol for peritonitis.Perit Dial Int1998; 18(3): 274–81.
115.
Van BiesenW., VeysN., VanholderR., LameireN.Peritonealdialysis-related peritonitis: The art of rope-dancing.Nephrol Dial Transplant2002; 17(11): 1878–82.
116.
KanG.W., ThomasM.A., HeathC.H.A 12-month review of peritoneal dialysis-related peritonitis in Western Australia: Is empiric vancomycin still indicated for some patients?Perit Dial Int2003; 23(5): 465–8.
117.
WongK.M., ChanY.H., CheungC.Y., ChakW.L., ChoiK.S., LeungS.H.Cefepime versus vancomycin plus netilmicin therapy for continuous ambulatory peritoneal dialysis-associated peritonitis.Am J Kidney Dis2001; 38(1): 127–31.
118.
VasS., BargmanJ., OreopoulosD.Treatment in PD patients of peritonitis caused by gram-positive organisms with single daily dose of antibiotics [see Comment].Perit Dial Int1997; 17(1): 91–4.
119.
TroidleL., Gorban-BrennanN., KligerA., FinkelsteinF.Once-daily intraperitoneal cefazolin and oral ciprofloxacin as empiric therapy for the treatment of peritonitis.Adv Perit Dial1999; 15: 213–16.
120.
SheminD., MaazD., St PierreD., KahnS.I., ChazanJ.A.Effect of aminoglycoside use on residual renal function in peritoneal dialysis patients.Am J Kidney Dis1999; 34(1): 14–20.
121.
SinghalM.K., BhaskaranS., VidgenE., BargmanJ.M., VasS.I., OreopoulosD.G.Rate of decline of residual renal function in patients on continuous peritoneal dialysis and factors affecting it [see Comment].Perit Dial Int2000; 20(4): 429–38.
122.
ShinS.K., NohH., KangS.W., SeoB.J., LeeI.H., SongH.Y.Risk factors influencing the decline of residual renal function in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19(2): 138–42.
123.
MulhernJ.G., BradenG.L., O'SheaM.H., MaddenR.L., LipkowitzG.S., GermainM.J.Trough serum vancomycin levels predict the relapse of gram-positive peritonitis in peritoneal dialysis patients.Am J Kidney Dis1995; 25(4): 611–15.
124.
LiP.K., IpM., LawM.C., SzetoC.C., LeungC.B., WongT.Y.Use of intraperitoneal cefepime as monotherapy in treatment of CAPD peritonitis.Perit Dial Int2000; 20(2): 232–4.
125.
KhairullahQ., ProvenzanoR., TayebJ., AhmadA., BalakrishnanR., MorrisonL.Comparison of vancomycin versus cefazolin as initial therapy for peritonitis in peritoneal dialysis patients.Perit Dial Int2002; 22(3): 339–44.
126.
FieldingR.E., ClemengerM., GoldbergL., BrownE.A.Treatment and outcome of peritonitis in automated peritoneal dialysis, using a once-daily cefazolin-based regimen.Perit Dial Int2002; 22(3): 345–9.
127.
ElwellR.J., BailieG.R., ManleyH.J.Correlation of intraperitoneal antibiotic pharmacokinetics and peritoneal membrane transport characteristics.Perit Dial Int2000; 20(6): 694–8.
DooleyD.P., TylerJ.R., WorthamW.G., HarrisonL.S., StarnesW.F.Jr., CollinsG.R.Prolonged stability of antimicrobial activity in peritoneal dialysis solutions.Perit Dial Int2003; 23(1): 58–62.
130.
FlaniganM.J., LimV.S.Initial treatment of dialysis associated peritonitis: A controlled trial of vancomycin versus cefazolin.Perit Dial Int1991; 11(1): 31–7.
ManleyH.J., BailieG.R., AsherR.D., EiseleG., FryeR.F.Pharmacokinetics of intermittent intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.Perit Dial Int1999; 19(1): 65–70.
133.
ManleyH.J., BailieG.R.Treatment of peritonitis in APD: Pharmacokinetic principles.Semin Dial2002; 15(6): 418–21.
134.
ManleyH.J., BridwellD.L., ElwellR.J., BailieG.R.Influence of peritoneal dialysate flow rate on the pharmacokinetics of cefazolin.Perit Dial Int2003; 23(5): 469–74.
135.
GucekA., BrenA.F., HergouthV., LindicJ.Cefazolin and netilmycin versus vancomycin and ceftazidime in the treatment of CAPD peritonitis.Adv Perit Dial1997; 13: 218–20.
136.
ZelenitskyS., BarnsL., FindlayI., AlfaM., ArianoR., FineA.Analysis of microbiological trends in peritoneal dialysis-related peritonitis from 1991 to 1998.Am J Kidney Dis2000; 36(5): 1009–13.
137.
LyeW.C., WongP.L., van der StraatenJ.C., LeongS.O., LeeE.J.A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.Adv Perit Dial1995; 11: 179–81.
138.
LyeW.C., van der StraatenJ.C., LeongS.O., SivaramanP., TanS.H., TanC.C.Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis.Perit Dial Int1999; 19(4): 357–60.
139.
BakerR.J., SeniorH., ClemengerM., BrownE.A.Empirical aminoglycosides for peritonitis do not affect residual renal function.Am J Kidney Dis2003; 41(3): 670–5.
140.
LeungC.B., SzetoC.C., ChowK.M., KwanB.C., WangA.Y., LuiS.F.Cefazolin plus ceftazidime versus imipenem/cilastatin monotherapy for treatment of CAPD peritonitis–a randomized controlled trial.Perit Dial Int2004; 24(5): 440–6.
141.
ChengI.K., FangG.X., ChauP.Y., ChanT.M., TongK.L., WongA.K.A randomized prospective comparison of oral levofloxacin plus intraperitoneal (IP) vancomycin and IP Netromycin plus IP vancomycin as primary treatment of peritonitis complicating CAPD.Perit Dial Int1998; 18(4): 371–5.
142.
LyeW.C., LeeE.J., van der StraatenJ.Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis.Perit Dial Int1993; 13(Suppl 2): S348–50.
143.
GoffinE., HerbietL., PouthierD., PochetJ.M., LafontaineJ.J., ChristopheJ.L.Vancomycin and ciprofloxacin: Systemic antibiotic administration for peritoneal dialysis-associated peritonitis.Perit Dial Int2004; 24(5): 433–9.
144.
YeungS.M., WalkerS.E., TailorS.A., AwdishuL., TobeS., YassaT.Pharmacokinetics of oral ciprofloxacin in continuous cycling peritoneal dialysis.Perit Dial Int2004; 24: 447–53.
145.
ChanM.K., ChengI.K., NgW.S.A randomized prospective trial of three different regimens of treatment of peritonitis in patients on continuous ambulatory peritoneal dialysis.Am J Kidney Dis1990; 15(2): 155–9.
146.
Perez-FontanM., RosalesM., FernandezF., MoncalianJ., Fernandez-RiveraC., AlonsoA.Ciprofloxacin in the treatment of gram-positive bacterial peritonitis in patients undergoing CAPD.Perit Dial Int1991; 11(3): 233–6.
147.
BoeschotenE.W., RietraP.J., KredietR.T., VisserM.J., AriszL.CAPD peritonitis: A prospective randomized trial of oral versus intraperitoneal treatment with cephradine.J Antimicrob Chemother1985; 16(6): 789–97.
148.
WilliamsonJ.C., VollesD.F., LynchP.L., RogersP.D., HaverstickD.M.Stability of cefepime in peritoneal dialysis solution.Ann Pharmacother1999; 33(9): 906–9.
149.
VogesM., FaictD., LechienG., TaminneM.Stability of drug additives in peritoneal dialysis solutions in a new container.Perit Dial Int2004; 24(6): 590–5.
150.
BoyceN.W., WoodC., ThomsonN.M., KerrP., AtkinsR.C.Intraperitoneal (IP) vancomycin therapy for CAPD peritonitis–a prospective, randomized comparison of intermittent v continuous therapy.Am J Kidney Dis1988; 12(4): 304–6.
151.
LowC.L., BailieG.R., EvansA., EiseleG., VeneziaR.A.Pharmacokinetics of once-daily IP gentamicin in CAPD patients [see Comment].Perit Dial Int1996; 16(4): 379–84.
152.
LowC.L., GopalakrishnaK., LyeW.C.Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients.J Am Soc Nephrol2000; 11(6): 1117–21.
153.
ManleyH.J., BailieG.R., FryeR., HessL.D., McGoldrickM.D.Pharmacokinetics of intermittent intravenous cefazolin and tobramycin in patients treated with automated peritoneal dialysis.J Am Soc Nephrol2000; 11(7): 1310–16.
KrishnanM., ThodisE., IkonomopoulosD., VidgenE., ChuM., BargmanJ.M.Predictors of outcome following bacterial peritonitis in peritoneal dialysis [see Comment].Perit Dial Int2002; 22(5): 573–81.
157.
SzetoC.C., ChowK.M., WongT.Y., LeungC.B., WangA.Y., LuiS.F.Feasibility of resuming peritoneal dialysis after severe peritonitis and Tenckhoff catheter removal.J Am Soc Nephrol2002; 13(4): 1040–5.
158.
FinkelsteinE.S., JekelJ., TroidleL., Gorban-BrennanN., FinkelsteinF.O., BiaF.J.Patterns of infection in patients maintained on long-term peritoneal dialysis therapy with multiple episodes of peritonitis [see Comment].Am J Kidney Dis2002; 39(6): 1278–86.
159.
DasguptaM.K., WardK., NobleP.A., LarabieM., CostertonJ.W.Development of bacterial biofilms on Silastic catheter materials in peritoneal dialysis fluid.Am J Kidney Dis1994; 23(5): 709–16.
160.
ReadR.R., EberweinP., DasguptaM.K., GrantS.K., LamK., NickelJ.C.Peritonitis in peritoneal dialysis: Bacterial colonization by biofilm spread along the catheter surface.Kidney Int1989; 35(2): 614–21.
161.
Munoz de BustilloE., AguileraA., JimenezC., BajoM.A., SanchezC., SelgasR.Streptococcal versus Staphylococcus epidermidis peritonitis in CAPD.Perit Dial Int1997; 17: 392–5.
162.
TroidleL., KligerA.S., Gorban-BrennanN., FikrigM., GoldenM., FinkelsteinF.O.Nine episodes of CPD-associated peritonitis with vancomycin resistant enterococci.Kidney Int1996; 50(4): 1368–72.
163.
AllcockN.M., KruegerT.S., ManleyH.J., KumarV.K., AbdallahJ.Linezolid disposition during peritonitis: A case report.Perit Dial Int2004; 24(1): 68–70.
164.
LynnW.A., ClutterbuckE., WantS., MarkidesV., LaceyS., RogersT.R.Treatment of CAPD-peritonitis due to glycopeptide-resistant Enterococcus faecium with quinupristin/dalfopristin.Lancet1994; 344(8928): 1025–6.
SzetoC.C., ChowK.M., LeungC.B., WongT.Y., WuA.K., WangA.Y.Clinical course of peritonitis due to Pseudomonas species complicating peritoneal dialysis: A review of 104 cases.Kidney Int2001; 59(6): 2309–15.
TroidleL., Gorban-BrennanN., KligerA., FinkelsteinF.Differing outcomes of gram-positive and gram-negative peritonitis.Am J Kidney Dis1998; 32(4): 623–8.
170.
SepandjF., CeriH., GibbA., ReadR., OlsonM.Minimum inhibitory concentration (MIC) versus minimum biofilm eliminating concentration (MBEC) in evaluation of antibiotic sensitivity of gram-negative bacilli causing peritonitis.Perit Dial Int2004; 24(1): 65–7.
171.
Valdes-SotomayorJ., CirugedaA., BajoM.A., del PesoG., EscuderoE., Sanchez-TomeroJ.A.Increased severity of Escherichia coli peritonitis in peritoneal dialysis patients independent of changes in in vitro antimicrobial susceptibility testing.Perit Dial Int2003; 23(5): 450–5.
172.
PrasadN., GuptaA., SharmaR.K., PrasadK.N., GulatiS., SharmaA.P.Outcome of gram-positive and gram-negative peritonitis in patients on continuous ambulatory peritoneal dialysis: A single center experience.Perit Dial Int2003; 23(Suppl 2): S144–7.
173.
TzanetouK., TriantaphillisG., TsoutsosD., PetropoulouD., GanterisG., Malamou-LadaE.Stenotrophomonas maltophilia peritonitis in CAPD patients: Susceptibility of antibiotics and treatment outcome: A report of five cases.Perit Dial Int2004; 24: 401–4.
174.
SteinerR.W., HalaszN.A.Abdominal catastrophes and other unusual events in continuous ambulatory peritoneal dialysis patients [see Comment].Am J Kidney Dis1990; 15(1): 1–7.
HolleyJ.L., BernardiniJ., PirainoB.Polymicrobial peritonitis in patients on continuous peritoneal dialysis.Am J Kidney Dis1992; 19(2): 162–6.
180.
HarwellC.M., NewmanL.N., CachoC.P., MulliganD.C., SchulakJ.A., FriedlanderM.A.Abdominal catastrophe: Visceral injury as a cause of peritonitis in patients treated by peritoneal dialysis.Perit Dial Int1997; 17(6): 586–94.
181.
AbrahamG., MathewsM., SekarL., SrikanthA., SekarU., SoundarajanP.Tuberculous peritonitis in a cohort of continuous ambulatory peritoneal dialysis patients.Perit Dial Int2001; 21(Suppl 3): S202–4.
182.
GuptaN., PrakashK.C.Asymptomatic tuberculous peritonitis in a CAPD patient.Perit Dial Int2001; 21(4): 416–17.
183.
HarroC., BradenG.L., MorrisA.B., LipkowitzG.S., MaddenR.L.Failure to cure Mycobacterium gordonae peritonitis associated with continuous ambulatory peritoneal dialysis.Clin Infect Dis1997; 24(5): 955–7.
184.
LuiS.L., TangS., LiF.K., ChoyB.Y., ChanT.M., LoW.K.Tuberculosis infection in Chinese patients undergoing continuous ambulatory peritoneal dialysis.Am J Kidney Dis2001; 38(5): 1055–60.
LyeW.C.Rapid diagnosis of Mycobacterium tuberculous peritonitis in two continuous ambulatory peritoneal dialysis patients, using DNA amplification by polymerase chain reaction.Adv Perit Dial2002; 18: 154–7.
187.
OgutmenB., TuglularS., Al AhdabH., AkogluE., OzenerQ.Tuberculosis peritonitis with clear fluid accompanying systemic disseminated tuberculosis in a CAPD patient.Perit Dial Int2003; 23(1): 95–6.
MitraA., TeitelbaumI.Is it safe to simultaneously remove and replace infected peritoneal dialysis catheters? Review of the literature and suggested guidelines.Adv Perit Dial2003; 19: 255–9.
190.
WilliamsA.J., BoletisI., JohnsonB.F., RafteryA.T., CohenG.L., MoorheadP.J.Tenckhoff catheter replacement or intraperitoneal urokinase: A randomised trial in the management of recurrent continuous ambulatory peritoneal dialysis (CAPD) peritonitis [see Comment].Perit Dial Int1989; 9(1): 65–7.
191.
WangQ., BernardiniJ., PirainoB., FriedL.Albumin at the start of peritoneal dialysis predicts the development of peritonitis.Am J Kidney Dis2003; 41(3): 664–9.
192.
TroidleL., WatnickS., WuerthD.B., Gorban-BrennanN., KligerA.S., FinkelsteinF.O.Depression and its association with peritonitis in long-term peritoneal dialysis patients.Am J Kidney Dis2003; 42(2): 350–4.
193.
ChangS., SievertD.M., HagemanJ.C., BoultonM.L., TenoverF.C., DownesF.P.Infection with vancomycin-resistant Staphylococcus aureus containing the vanA resistance gene.N Engl J Med2003; 348(14): 1342–7.
